E-LIB Suche - Ergebnisse für: Kadokura, Takeshi

1

Clinical Pharmacology of the Antibody–Drug Conjugate Enfort..:

Tang, Mei ; Garg, Amit ; Bonate, Peter L....
Clinical Pharmacokinetics. 63 (2024) 4 - p. 423-438 , 2024

2

Correction to: Pharmacokinetic Profile of Gilteritinib: A N..:

James, Angela Joubert ; Smith, Catherine C. ; Litzow, Mark...
Clinical Pharmacokinetics. 60 (2021) 9 - p. 1251-1251 , 2021

Link: https://doi.org/10.1007/..

3

Model-based Prediction of the Long-term Glucose-Lowering Ef..:

Saito, Masako ; Kaibara, Atsunori ; Kadokura, Takeshi...
Diabetes Therapy. 11 (2020) 4 - p. 951-964 , 2020

Link: https://doi.org/10.1007/..

4

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyro..:

James, Angela Joubert ; Smith, Catherine C. ; Litzow, Mark...
Clinical Pharmacokinetics. 59 (2020) 10 - p. 1273-1290 , 2020

Link: https://doi.org/10.1007/..

5

Pharmacokinetic and pharmacodynamic modelling for renal fun..:

Saito, Masako ; Kaibara, Atsunori ; Kadokura, Takeshi...
British Journal of Clinical Pharmacology. 85 (2019) 8 - p. 1808-1819 , 2019

Link: https://doi.org/10.1111/..

6

A phase I study of enfortumab vedotin in Japanese patients ..:

Takahashi, Shunji ; Uemura, Motohide ; Kimura, Tomokazu...
Investigational New Drugs. 38 (2019) 4 - p. 1056-1066 , 2019

Link: https://doi.org/10.1007/..

7

The pharmacokinetics of darexaban (YM150), an oral direct f..:

Groenendaal, Dorien ; Strabach, Gregory ; Garcia‐Hernandez, Alberto...
Clinical Pharmacology in Drug Development. 3 (2014) 3 - p. 194-201 , 2014

Link: https://doi.org/10.1002/..

8

Pharmacokinetic and pharmacodynamic study of ipragliflozin ..:

Kadokura, Takeshi ; Akiyama, Noriko ; Kashiwagi, Atsunori...
Diabetes Research and Clinical Practice. 106 (2014) 1 - p. 50-56 , 2014

Link: https://doi.org/10.1016/..

9

Clinical Pharmacokinetics and Pharmacodynamics of the Novel..:

Kadokura, Takeshi ; Zhang, Wenhui ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 53 (2014) 11 - p. 975-988 , 2014

Link: https://doi.org/10.1007/..

10

Ipragliflozin Does Not Prolong QTc Interval in Healthy Male..:

Zhang, Wenhui ; Smulders, Ronald ; Abeyratne, Anura...
Clinical Therapeutics. 35 (2013) 8 - p. 1150-1161.e3 , 2013

Link: https://doi.org/10.1016/..

11

Darexaban (YM150), an oral direct factor Xa inhibitor, has ..:

Kadokura, Takeshi ; Groenendaal, Dorien ; Heeringa, Marten...
European Journal of Drug Metabolism and Pharmacokinetics. 39 (2013) 1 - p. 1-9 , 2013

Link: https://doi.org/10.1007/..

12

The pharmacokinetics of darexaban are not affected to a cli..:

Groenendaal, Dorien ; Strabach, Gregory ; Garcia‐Hernandez, Alberto...
British Journal of Clinical Pharmacology. 75 (2013) 2 - p. 440-449 , 2013

Link: https://doi.org/10.1111/..

13

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tol..:

Kadokura, Takeshi ; Oikawa, Keishi ; Miyata, Koji..
Clinical Pharmacology in Drug Development. 2 (2013) 4 - p. 328-335 , 2013

Link: https://doi.org/10.1002/..

14

Clinical pharmacokinetics, pharmacodynamics, safety and tol..:

Kadokura, Takeshi ; Kashiwa, Makoto ; Groenendaal, Dorien...
Biopharmaceutics & Drug Disposition. 34 (2013) 8 - p. 431-441 , 2013

Link: https://doi.org/10.1002/..

15

Renal Glucose Handling:

Ferrannini, Ele ; Veltkamp, Stephan A. ; Smulders, Ronald A..
Diabetes Care. 36 (2013) 5 - p. 1260-1265 , 2013

Link: https://doi.org/10.2337/..